Literature DB >> 19097785

Chitooligosaccharides suppress the level of protein expression and acetylcholinesterase activity induced by Abeta25-35 in PC12 cells.

Sang-Hoon Lee1, Jin-Sook Park, Se-Kwon Kim, Chang-Bum Ahn, Jae-Young Je.   

Abstract

Clinical applications of acetylcholinesterase (AChE) inhibitors are widespread in Alzheimer's sufferers in order to activate central cholinergic system and alleviate cognitive deficits by inhibiting the hydrolysis of acetylcholine. In this study, six kinds of chitooligosaccharides (COSs) with different molecular weight and degree of deacetylation were examined for their inhibitory effects against AChE. The 90-COSs exhibited potent AChE inhibitory activities compared to 50-COSs, while 90-MMWCOS (1000-5000 Da) in the 90-COSs showed the highest activity. Cell culture experiment revealed that 90-MMWCOS suppressed the level of AChE protein expression and AChE activity induced by Abeta(25-35) in PC12 cell lines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19097785     DOI: 10.1016/j.bmcl.2008.12.019

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

Review 1.  Neuroprotective properties of chitosan and its derivatives.

Authors:  Ratih Pangestuti; Se-Kwon Kim
Journal:  Mar Drugs       Date:  2010-07-09       Impact factor: 5.118

2.  Acetylated chitosan oligosaccharides act as antagonists against glutamate-induced PC12 cell death via Bcl-2/Bax signal pathway.

Authors:  Cui Hao; Lixia Gao; Yiran Zhang; Wei Wang; Guangli Yu; Huashi Guan; Lijuan Zhang; Chunxia Li
Journal:  Mar Drugs       Date:  2015-03-12       Impact factor: 5.118

3.  Natural products as promising drug candidates for the treatment of Alzheimer's disease: molecular mechanism aspect.

Authors:  Niloufar Ansari; Fariba Khodagholi
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

4.  Membrane bioreactor technology for the development of functional materials from sea-food processing wastes and their potential health benefits.

Authors:  Se-Kwon Kim; Mahinda Senevirathne
Journal:  Membranes (Basel)       Date:  2011-10-25

Review 5.  An Overview of the Protective Effects of Chitosan and Acetylated Chitosan Oligosaccharides against Neuronal Disorders.

Authors:  Cui Hao; Wei Wang; Shuyao Wang; Lijuan Zhang; Yunliang Guo
Journal:  Mar Drugs       Date:  2017-03-23       Impact factor: 5.118

Review 6.  Study of Nutraceuticals and Phytochemicals for the Management of Alzheimer's Disease: A Review.

Authors:  Syed Sayeed Ahmad; Mohammad Khalid; Mohammad A Kamal; Kaiser Younis
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

Review 7.  Potential Medical Applications of Chitooligosaccharides.

Authors:  Sukumaran Anil
Journal:  Polymers (Basel)       Date:  2022-08-29       Impact factor: 4.967

Review 8.  Application of Chitosan, Chitooligosaccharide, and Their Derivatives in the Treatment of Alzheimer's Disease.

Authors:  Qian-Qian Ouyang; Shannon Zhao; Si-Dong Li; Cai Song
Journal:  Mar Drugs       Date:  2017-11-07       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.